Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants

Clinical trial NCT00143312 · COMPLETED

Trial details

NCT number: NCT00143312
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Prophylaxis Of Invasive Fungal Infections

Start date: 2005-02-01
Primary completion: 2008-04-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.